Literature DB >> 20638239

Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis.

Francesca Bernuzzi1, Daniela Fenoglio, Florinda Battaglia, Marco Fravega, M Eric Gershwin, Francesco Indiveri, Aftab A Ansari, Mauro Podda, Pietro Invernizzi, Gilberto Filaci.   

Abstract

The mechanisms that lead to loss of tolerance in autoimmune disease have remained both elusive and diverse, including both genetic predisposition and generic dysregulation of critical mononuclear cell subsets. In primary biliary cirrhosis (PBC), patients exhibit a multilineage response to the E2 component of pyruvate dehydrogenase involving antibody as well as autoreactive CD4 and CD8 responses. Recent data from murine models of PBC have suggested that a critical mechanism of biliary destruction is mediated by liver-infiltrating CD8 cells. Further, the number of autoreactive liver-infiltrating CD4 and CD8 cells is significantly higher in liver than blood in patients with PBC. Based on this data, we have studied the frequencies and phenotypic characterization of both CD4 and CD8 regulatory T cell components in both patients with PBC and age-sex matched controls. Our data is striking and indicate that CD8 Treg populations from PBC patients, but not controls, have significant phenotypic alterations, including increased expression of CD127 and reduced CD39. Furthermore, in vitro induction of CD8 Tregs by incubation with IL10 is significantly reduced in PBC patients. Importantly, the frequencies of circulating CD4+CD25+ and CD8+ and CD28- T cell subpopulations are not significantly different between patients and controls. In conclusion, these data identify the CD8 Treg subset as a regulatory T cell subpopulation altered in patients with PBC.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20638239      PMCID: PMC3150737          DOI: 10.1016/j.jaut.2010.06.004

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  58 in total

1.  Bone marrow transplantation, refractory autoimmunity and the contributions of Susumu Ikehara.

Authors:  M Eric Gershwin
Journal:  J Autoimmun       Date:  2008-05       Impact factor: 7.094

2.  Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice.

Authors:  Guo-Xiang Yang; Zhe-Xiong Lian; Ya-Hui Chuang; Yuki Moritoki; Ruth Y Lan; Kanji Wakabayashi; Aftab A Ansari; Richard A Flavell; William M Ridgway; Ross L Coppel; Koichi Tsuneyama; Ian R Mackay; M Eric Gershwin
Journal:  Hepatology       Date:  2008-06       Impact factor: 17.425

3.  CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness.

Authors:  Norikatsu Mizumoto; Tadashi Kumamoto; Simon C Robson; Jean Sévigny; Hiroyuki Matsue; Keiichi Enjyoji; Akira Takashima
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

4.  Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice.

Authors:  Sabine Oertelt; Zhe-Xiong Lian; Chun-Mei Cheng; Ya-Hui Chuang; Kerstien A Padgett; Xiao-Song He; William M Ridgway; Aftab A Ansari; Ross L Coppel; Ming O Li; Richard A Flavell; Mitchell Kronenberg; Ian R Mackay; M Eric Gershwin
Journal:  J Immunol       Date:  2006-08-01       Impact factor: 5.422

Review 5.  The causes of primary biliary cirrhosis: Convenient and inconvenient truths.

Authors:  M Eric Gershwin; Ian R Mackay
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

Review 6.  Why can't we find a new treatment for SLE?

Authors:  Robert Eisenberg
Journal:  J Autoimmun       Date:  2009-03-28       Impact factor: 7.094

7.  Autoreactive human T-cell receptor initiates insulitis and impaired glucose tolerance in HLA DR4 transgenic mice.

Authors:  John A Gebe; Kellee A Unrath; Betty B Yue; Tom Miyake; Ben A Falk; Gerald T Nepom
Journal:  J Autoimmun       Date:  2007-10-18       Impact factor: 7.094

8.  A tribute to an outstanding immunologist - Ian Reay Mackay.

Authors:  Senga Whittingham; Merrill J Rowley; M Eric Gershwin
Journal:  J Autoimmun       Date:  2008-05-27       Impact factor: 7.094

9.  Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.

Authors:  Gilberto Filaci; Marco Fravega; Simone Negrini; Francesco Procopio; Daniela Fenoglio; Marta Rizzi; Sabrina Brenci; Paola Contini; Daniel Olive; Massimo Ghio; Maurizio Setti; Roberto S Accolla; Francesco Puppo; Francesco Indiveri
Journal:  Hum Immunol       Date:  2004-02       Impact factor: 2.850

10.  Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Ralpha(-/-) mice.

Authors:  Willy Hsu; Weici Zhang; Koichi Tsuneyama; Yuki Moritoki; William M Ridgway; Aftab A Ansari; Ross L Coppel; Zhe-Xiong Lian; Ian Mackay; M Eric Gershwin
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

View more
  27 in total

1.  Primary biliary cirrhosis: bad genes, bad luck.

Authors:  Pietro Invernizzi; M Eric Gershwin
Journal:  Dig Dis Sci       Date:  2012-03       Impact factor: 3.199

2.  Increased numbers of circulating ICOS⁺ follicular helper T and CD38⁺ plasma cells in patients with newly diagnosed primary biliary cirrhosis.

Authors:  Li Wang; Xiguang Sun; Jinpeng Qiu; Yanjun Cai; Liang Ma; Pingwei Zhao; Yanfang Jiang
Journal:  Dig Dis Sci       Date:  2014-11-18       Impact factor: 3.199

3.  Etiopathogenesis of primary biliary cirrhosis: an overview of recent developments.

Authors:  Palak J Trivedi; Sue Cullen
Journal:  Hepatol Int       Date:  2012-03-20       Impact factor: 6.047

4.  Efficacy of ursodeoxycholic acid combined with Tongdan Decoction () on immunological indices and histopathological changes in primary biliary cirrhosis patients.

Authors:  Guang-Dong Tong; Hai-Hong Tang; Chun-Shan Wei; Ying-Jie Chen; Jin-Song He; Xiao-Zhou Zhou; Ying-Jun Zheng; Da-Qiao Zhou
Journal:  Chin J Integr Med       Date:  2012-01-10       Impact factor: 1.978

5.  Trichloroethylene Exposure Reduces Liver Injury in a Mouse Model of Primary Biliary Cholangitis.

Authors:  Jessica L Ray; Anna K Kopec; Nikita Joshi; Holly Cline-Fedewa; Lawrence H Lash; Kurt J Williams; Patrick S Leung; M Eric Gershwin; James P Luyendyk
Journal:  Toxicol Sci       Date:  2017-04-01       Impact factor: 4.849

Review 6.  Role of autoimmunity in primary biliary cirrhosis.

Authors:  Tian-Yan Shi; Feng-Chun Zhang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

7.  Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cells.

Authors:  Wenting Huang; Kritika Kachapati; David Adams; Yuehong Wu; Patrick S C Leung; Guo-Xiang Yang; Weici Zhang; Aftab A Ansari; Richard A Flavell; M Eric Gershwin; William M Ridgway
Journal:  J Autoimmun       Date:  2014-02-18       Impact factor: 7.094

Review 8.  Proposed therapies in primary biliary cholangitis.

Authors:  Annarosa Floreani; Ying Sun; Zheng Sheng Zou; Baosen Li; Nora Cazzagon; Christopher L Bowlus; M Eric Gershwin
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2016-01-06       Impact factor: 3.869

Review 9.  Environmental factors in primary biliary cirrhosis.

Authors:  Brian D Juran; Konstantinos N Lazaridis
Journal:  Semin Liver Dis       Date:  2014-07-24       Impact factor: 6.115

10.  Xenobiotics and autoimmunity: does acetaminophen cause primary biliary cirrhosis?

Authors:  Patrick S C Leung; Kit Lam; Mark J Kurth; Ross L Coppel; M Eric Gershwin
Journal:  Trends Mol Med       Date:  2012-08-21       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.